CL2021000973A1 - New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
CL2021000973A1
CL2021000973A1 CL2021000973A CL2021000973A CL2021000973A1 CL 2021000973 A1 CL2021000973 A1 CL 2021000973A1 CL 2021000973 A CL2021000973 A CL 2021000973A CL 2021000973 A CL2021000973 A CL 2021000973A CL 2021000973 A1 CL2021000973 A1 CL 2021000973A1
Authority
CL
Chile
Prior art keywords
pyrimidonyl
preparation
pharmaceutical compositions
compositions containing
new amino
Prior art date
Application number
CL2021000973A
Other languages
Spanish (es)
Inventor
András Kotschy
Olivier Geneste
James Brooke Murray
Didier Demarles
Csaba Wéber
Andrea Fiumana
Attila Vasas
Balázs Molnár
Árpád Kiss
Alba Macias
Lisa Ivanschitz
Kristóf Hegedüs
Péter Spránitz
Tibor SOÓS
Original Assignee
Servier Lab
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis R&D Ltd filed Critical Servier Lab
Publication of CL2021000973A1 publication Critical patent/CL2021000973A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compuestos de fórmula (I): (I) en donde R1, R2, R3, R4, R5, n y Q son como se definen en la descripción. Medicamentos.Compounds of formula (I): (I) where R1, R2, R3, R4, R5, n and Q are as defined in the description. Medicines.

CL2021000973A 2018-10-19 2021-04-16 New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them. CL2021000973A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18306377 2018-10-19
EP19305936 2019-07-12

Publications (1)

Publication Number Publication Date
CL2021000973A1 true CL2021000973A1 (en) 2021-11-19

Family

ID=68234009

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021000973A CL2021000973A1 (en) 2018-10-19 2021-04-16 New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them.

Country Status (24)

Country Link
US (1) US20210355106A1 (en)
EP (1) EP3866930A1 (en)
JP (1) JP2022505122A (en)
KR (1) KR20210081371A (en)
CN (1) CN113038990A (en)
AU (1) AU2019360391A1 (en)
BR (1) BR112021006714A2 (en)
CA (1) CA3116089A1 (en)
CL (1) CL2021000973A1 (en)
CO (1) CO2021004553A2 (en)
CR (1) CR20210173A (en)
DO (1) DOP2021000063A (en)
EC (1) ECSP21024078A (en)
IL (1) IL282218A (en)
JO (1) JOP20210063A1 (en)
MA (1) MA53900A (en)
MX (1) MX2021004379A (en)
NI (1) NI202100024A (en)
PE (1) PE20211649A1 (en)
PH (1) PH12021550788A1 (en)
SG (1) SG11202103279RA (en)
TW (1) TW202028188A (en)
UY (1) UY38423A (en)
WO (1) WO2020079205A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20220294A (en) 2019-12-20 2022-08-03 Bayer Ag Substituted thiophene carboxamides, thiophene carboxylic acids and derivatives thereof
CN114507163A (en) * 2020-11-16 2022-05-17 尚科生物医药(上海)有限公司 Method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3052452B1 (en) * 2016-06-10 2018-06-22 Les Laboratoires Servier NOVEL PIPERIDINYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PE20220948A1 (en) * 2016-06-10 2022-05-31 Servier Lab NEW PIPERIDINIL DERIVATIVES SUBSTITUTED WITH (HETERO) ARYL, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB201617758D0 (en) * 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds

Also Published As

Publication number Publication date
PH12021550788A1 (en) 2021-10-18
CO2021004553A2 (en) 2021-04-30
KR20210081371A (en) 2021-07-01
WO2020079205A1 (en) 2020-04-23
EP3866930A1 (en) 2021-08-25
UY38423A (en) 2021-02-26
IL282218A (en) 2021-05-31
PE20211649A1 (en) 2021-08-24
CR20210173A (en) 2021-05-11
ECSP21024078A (en) 2021-05-31
JOP20210063A1 (en) 2023-01-30
NI202100024A (en) 2021-08-24
DOP2021000063A (en) 2021-08-31
MA53900A (en) 2022-01-26
TW202028188A (en) 2020-08-01
CA3116089A1 (en) 2020-04-23
BR112021006714A2 (en) 2021-07-27
SG11202103279RA (en) 2021-04-29
AU2019360391A1 (en) 2021-05-13
CN113038990A (en) 2021-06-25
US20210355106A1 (en) 2021-11-18
MX2021004379A (en) 2021-06-04
JP2022505122A (en) 2022-01-14

Similar Documents

Publication Publication Date Title
NI201800076A (en) NEW AMMONIUM DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
NI201800132A (en) NEW PIPERIDINYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NI201800133A (en) NEW PIPERIDINYL DERIVATIVES SUBSTITUTED WITH (HETERO) ARILO, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DOP2017000304A (en) NEW HYDROXY ACID DERIVATIVES, A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ECSP17083003A (en) NEW BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ECSP17081744A (en) NEW HYDROXYESTER DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
CU20140143A7 (en) NEW TIENOPIRIMIDINE DERIVATIVES, A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CR20170590A (en) NEW HYDROXY ACID DERIVATIVES, A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DOP2018000082A (en) NEW DERIVATIVES OF PIRROLO [2,3-d] PYRIMIDINE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DOP2018000083A (en) NEW DERIVATIVES OF IMIDAZO [4,5-b] PIRIDINA, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CL2021000973A1 (en) New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them.
UY38291A (en) NEW AMINO-PYRIMIDONYL DERIVATIVES A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS